Articles tagged with Dementia
A new study published in Alzheimer's & Dementia found that telmisartan, a blood pressure medication, is associated with lower risk of Alzheimer's specifically in Black patients over 60. The study analyzed data from over 5 million patients and suggests that future clinical trials should prioritize minority populations to find or reinfor...
A study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring found that analyzing patients' speech can distinguish between different types of dementia. The research team developed a machine learning model using speech features to identify Alzheimer's disease and Lewy body dementia.
A new poll finds that more than half of people over 50 have helped at least one person over 65 with various tasks, including health care needs, home repairs, and finances. The experience can be rewarding but also challenging, especially for those helping individuals with complex needs.
A study published in the Journal of Alzheimer's Disease found that analyzing patients' drawing tests can help diagnose Alzheimer's disease (AD) and distinguish it from dementia with Lewy bodies (DLB). The researchers discovered that DLB patients showed differences in speed-, pressure-, and pause-related features, whereas AD patients sh...
A new study found that only 12% of middle-aged adults are willing to participate in dementia prevention drug trials, citing concerns over the risks involved. The study suggests prioritizing those with a family history or perceived personal risk for dementia and communicating about trial safety could increase participation.
Scientists have developed a new mathematical model to understand the formation of amyloid protein clusters in the brain, which are linked to Alzheimer's disease. The study reveals that these clusters form through a process called liquid-liquid phase separation and can impact normal brain activity.
A new funding grant will be used to investigate the effectiveness of 'Fastball EEG' in detecting three major types of dementia, including frontotemporal dementia and Vascular Dementia. The technology has shown high accuracy in picking up small changes in brain waves associated with memory recall.
Researchers at Harvard Medical School have made progress in understanding the mechanism underlying a type of dementia that strikes early in life. A genetic form of frontotemporal dementia is associated with accumulation of specific lipids in the brain, which results from a protein deficiency that interferes with cell metabolism.
A new study published in NEJM Evidence found that crossword puzzle training significantly improved cognitive function and daily activities, reducing brain shrinkage in individuals with mild cognitive impairment. The findings suggest that engaging with familiar activities like crossword puzzles may be more effective than computerized co...
A team of researchers at USC is launching a comprehensive study to investigate the connection between type 2 diabetes and dementia in adults with Hispanic ancestry. The five-year study will examine brain structure and activity, blood flow, blood glucose and insulin levels, and cognitive functioning in 200 participants.
Researchers at Penn State aim to create a minimally invasive system using machine learning and multimodal biosensing platforms to detect Alzheimer's disease in its early stages. The system has the potential to improve detection accuracy and reduce false positives.
A meta-analysis published in Neurology found an association between traffic-related air pollution and an increased risk of dementia. Fine particulate matter exposure was linked to a 3% increase in dementia risk, highlighting the importance of reducing air pollution to prevent this disease.
A global study of over 28,000 people found that lowering blood pressure can significantly reduce the risk of dementia. The researchers analyzed five double-blind placebo-controlled trials and discovered a broad linear relationship between blood pressure reduction and lower dementia risk.
A recent US study of nearly 3,500 individuals aged 65+ found that 10% had dementia and 22% mild cognitive impairment (MCI), with disparities seen among racial and educational groups. The results highlight the disproportionate burden of dementia on older Black adults and MCI among Hispanic adults with lower education levels.
A recent study found that nearly 10% of US adults aged 65 and older have dementia, while another 22% have mild cognitive impairment. The prevalence of dementia and mild cognitive impairment increases with age, affecting individuals from diverse backgrounds differently.
Researchers found lower serum TDP-43 levels in patients with C9orf72 repeat expansion or motoneuron disease, distinguishing them from other FTD subtypes. This study suggests TDP-43 as a potential biomarker for diagnosing specific FTD subtypes, enabling patient-specific interventions.
Scientists at NTU Singapore have found that a stress response in cells, when 'switched on' at a post-reproductive age, could be the key to slowing down aging. The study showed that this stress response extended the lifespan of roundworms fed a high-glucose diet.
A population-based analysis of 1,193 major surgeries found that 13.4% of patients died within a year, with frail and dementia-affected individuals facing significantly higher mortality rates
A new study found that timely treatment of depression can reduce the risk of dementia by about 30% in certain patient groups. The study, published in Biological Psychiatry, analyzed data from over 350,000 participants and found that depression elevated the risk of dementia by 51%, but treatment reduced this risk. Those with increasing ...
A new study aims to diagnose severe neurodegenerative diseases like ALS and FTD with the help of speech tests. AI can analyze subtle nuances of speech patterns, including pauses, speed, and melodic aspects, to detect early changes.
A new study by UCL researchers found that talking therapies on the NHS can improve the mental health of people with dementia, with 63% experiencing a reduction in symptoms. The therapy proved clinically beneficial, even though response rates were lower than those without dementia.
A new study published in Neurology found that following a Mediterranean diet did not decrease the risk of dementia. The study, which followed 28,000 participants over 20 years, found no link between adhering to conventional dietary recommendations or the Mediterranean diet and reduced risk of dementia.
A recent UK Biobank study found that Black participants are at a higher risk of developing dementia compared to White participants, with an HR of 1.43. South Asians also have a similar risk to White participants. The study included 294,000 volunteers, but the results may not be representative of the wider UK population.
A recent study analyzed the records of over 33,000 dementia patients in Wales and found that those closest to their diagnosis were taking an average of three or more medications. This suggests a possible link between polypharmacy and the development of dementia.
Researchers have identified cognitive impairment in patients with dementia-related diseases up to 9 years before diagnosis, raising hope for earlier interventions and clinical trial recruitment. The study analyzed UK Biobank data and found subtle impairments in problem-solving and memory across various conditions.
Researchers found that higher levels of cell-free DNA in the blood are associated with increased cognitive decline and worsening frailty over an eight-year period. The study suggests that a simple blood test could detect risk of Alzheimer's disease and other forms of cognitive decline, potentially leading to early interventions.
A Baycrest study found that the gut microbiome plays a role in how diet and exercise affect brain health and dementia risk. Lifestyle interventions like Mediterranean-style diets can improve cognition and promote healthier microbiomes.
A long-term study found that older patients with type 2 diabetes treated with glitazones had a 22% lower risk of developing dementia. These drugs may effectively prevent dementia in high-risk patients and are now worth prioritizing for future clinical studies.
Researchers found positive correlations between lipoxin A4 and cognitive brain functions, as well as its potential to potentiate the endocannabinoid system. The study suggests that reducing levels of this substance may weaken the body's defenses against neurodegeneration.
Researchers analyzing over 3,000 blood samples from Alzheimer's patients and healthy individuals to identify reliable biomarkers. They investigate how well blood tests can diagnose Alzheimer's disease and predict its progression.
A new study found that caregivers, particularly women, experience higher odds of health-related vulnerabilities such as food insecurity and financial strain. Caregivers must balance their own lives with those of their dependents, finding ways to care for themselves while dedicating time to caring for loved ones.
A systematic review and meta-analysis found that psychotic disorders like schizophrenia are associated with a higher risk of developing dementia. People with psychotic disorders are 2.5 times more likely to develop dementia than those without a psychotic disorder, according to the review.
Researchers at Lancaster University found that 3D printed flavor-based cues can stimulate rich sensory accounts and strong emotional connections in older adults, recalling memories from their youth. This technology has potential applications for dementia care, allowing individuals to relive cherished moments through the power of smell.
A study published in Nature has identified 61 additional genetic loci associated with stroke and six genes that are potential targets for drug therapy. The research also found a significant overlap between stroke and dementia, suggesting common biology between the two conditions.
Research has found that former Scottish international rugby union players are at a significantly increased risk of developing neurodegenerative diseases, including dementia and motor neurone disease. The study's findings suggest that strategies to reduce head impact and traumatic brain injury in all sports are necessary.
The I-CARE 2 trial will measure the impact of Brain CareNotes on informal caregivers and patients with Alzheimer's disease and related dementia. The randomized clinical trial aims to improve caregiver burden, depressive symptoms, and healthcare outcomes.
A study by Queen Mary University of London and University of Nottingham found that patients with young onset dementia are at a high risk of suicide, particularly if under 65 or have psychiatric illness. Early recognition and support after diagnosis are crucial in reducing distress caused by this devastating condition.
A nationally representative study of 594,000 persons in England found an increased risk of suicide associated with dementia diagnosis before age 65. The study identified younger patients diagnosed within the 3-month post-diagnostic period as high-risk groups for suicidal thoughts and behaviors.
A new study found that fewer Asian, Black, and Hispanic patients qualify for anti-amyloid monoclonal antibody treatments, which may slow Alzheimer's progression. The treatment's effectiveness depends on the presence of amyloid plaques, with lower incidence in minorities.
A study from UniSA researchers found associations between metabolic profiles and adverse brain findings, including lower hippocampal and grey matter volumes. People with metabolic profiles linked to obesity were more likely to have higher accumulation of iron in the brain.
A Rutgers study found that racial and ethnic minorities with dementia receive more intensive end-of-life care. This disparity may be attributed to systemic racism, discrimination, or poor physician communication. The researchers suggest improving end-of-life care and outcomes for people with dementia through initiatives like advance ca...
Researchers developed a machine learning model to quickly recognize predictive risk factors and their importance for undesirable hospitalization outcomes. The model achieved an accuracy of 95.6% and identified modifiable risk factors that can be mitigated through clinical interventions.
The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.
A study found that aberrant expression of MAO-B causes both peripheral and neuroinflammation in RA patients, leading to joint pain and cognitive impairment. Administering an MAO-B inhibitor called KDS2010 improved both joint inflammation and cognitive function in a RA animal model.
A new study finds that high blood pressure speeds up cognitive decline in both Hispanic and non-Hispanic white adults. However, differences in blood pressure control do not fully explain the higher risk of dementia in Hispanic adults.
Researchers have discovered that neurons with double-stranded breaks (DSBs) in their DNA actively trigger an inflammatory response, which is mediated by the activation of the NFkappaB transcription factor. This process elicits an immune response from microglia, leading to synaptic loss and cognitive function impairment.
Scientists have made a groundbreaking discovery about the role of 'junk' DNA in neurological disorders such as Motor Neurone Disease and Alzheimer's. The research found that breaks in this type of DNA can lead to oxidative genomic damage, which can accelerate aging and disease progression.
A new study found that certain pre-existing conditions have a more significant impact on COVID-19 outcomes than previously thought. Researchers developed a novel prediction model, PDeathDx, which outperformed conventional models and identified degenerative neurological diseases, dementia, and severe disabilities as major risk factors.
The fasting-mimicking diet reduced Alzheimer's pathology in mice, including amyloid beta and tau protein levels, and showed less brain inflammation. Mice on the diet also performed better on cognitive tests, with some showing improved performance comparable to non-Alzheimer's mice.
Reduced kidney function and increased urine albumin excretion are associated with brain volume reduction in regions typically affected by Alzheimer's disease and other dementia etiologies. Cognitive decline is common in patients with kidney disease, and this study provides new insights into the etiology and localization of brain damage.
A mortality prediction model for older adults with dementia can guide discussions about financial resources, treatment preferences, and reduce unnecessary medical interventions. The model considers factors such as age, sex, body mass index, chronic conditions, and ability to perform daily activities.
A $1 million NIH grant will help MU researchers analyze the effectiveness of a HIPAA-secure text messaging platform in nursing homes. The study aims to improve quality of care and prevent costly hospital transfers by speeding up decision-making.
A new study proposes reducing toxic proteins in the blood as a potential therapy for Alzheimer's disease. By doing so, it aims to improve memory and learning capacity, as well as correct cognitive impairments. The next step is to test this treatment at a clinical level.
A global consortium study aims to understand the impact of SARS-CoV-2 on the brain, with researchers evaluating over 1,000 participants worldwide. The study, led by UT Health San Antonio, uses advanced brain imaging and neuropsychological tests to assess cognitive function and identify potential causes of long-term brain changes.
A cohort study of Chinese older adults found that sleeping for more than 8 hours increases dementia risk by 69% and going to bed before 9 PM doubles the risk. The study suggests monitoring cognitive function in those with prolonged sleep timing.
Research at the University of Birmingham suggests that people who experience frequent bad dreams in middle age are more likely to be diagnosed with dementia later in life. The study found that middle-aged individuals with weekly nightmares were four times more likely to experience cognitive decline over a decade.
Neflamapimod, a p38α kinase inhibitor, demonstrates reversible neurodegeneration in animal models and improves clinical endpoints associated with cholinergic neuronal function in patients with dementia with Lewy bodies. The findings support the initiation of a confirmatory Phase 2b clinical trial for neflamapimod.
A new study from Michigan Medicine found that adults with more chronic health conditions are at higher risk of serious financial problems, including late payments, poor credit scores, and bankruptcy. The study analyzed nearly 3 million privately insured adults and found that those with seven or more chronic conditions had three to four...
The study used a weakly supervised deep learning algorithm to analyze human brain autopsy tissues and predict the presence or absence of cognitive impairment. The model identified a signal associated with decreasing myelin staining, which was linked to cognitive impairment in the white matter.
A mutation in the SHMOOSE protein is associated with a 20-50% higher risk of Alzheimer's disease across four cohorts. The researchers suggest that targeting SHMOOSE may prove beneficial in neurodegenerative and other diseases of aging.